APTIMA INC - DHA PHASE II SBIR MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2-0810

PIID: HT942525C0008

Signed Date: Nov 24, 2025Effective Date: Feb 12, 2025End Date: Closes in 368 days

Award $

$1.3M

Vendor

APTIMA INC

NAICS

541715

Signed Date

Nov 24, 2025

Key Details

Dollars Obligated

$1.3M

Base & All Options

Awarding Agency

Department of Defense

Awarding Sub-Agency

Defense Health Agency

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES

Number of Offers

Place of Performance

WOBURN, MA, 018011190, CD-MA-05

Description

DHA PHASE II SBIR MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2-0810

Context & Analysis

On Nov 24, 2025, Department of Defense obligated $1,299,982.96 to APTIMA INC for dha phase ii sbir medical r&d contract from proposal no. h2-0810. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 3 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in WOBURN, MA. The contract is scheduled through Jun 11, 2027 — approximately 12 months remaining.